Literature DB >> 6346494

The systemic chemotherapy of hepatic metastases.

N Kemeny.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6346494

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


× No keyword cloud information.
  13 in total

1.  CAF versus CAF plus Medroxyprogesterone Acetate for Treatment of Liver Metastases of Breast Cancer.

Authors: 
Journal:  Breast Cancer       Date:  1995-04-30       Impact factor: 4.239

2.  Intraarterial hepatic chemotherapy with fluorouracil, fluorodeoxyuridine, mitomycin C, cisplatin or methotrexate as single-agent anticancer drugs for a transplanted experimental liver tumor in rats.

Authors:  S Kurth; D Bulian; B Kreft; T Riemenschneider
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

3.  Regional infusion of fluoropyrimidines for hepatic metastases of colorectal cancer.

Authors:  C H Koks; J R Brouwers; D T Sleijfer
Journal:  Pharm Weekbl Sci       Date:  1988-04-22

4.  Ultrasound-guided thermal radiofrequency ablation (RFA) as an adjunct to systemic chemotherapy for breast cancer liver metastases.

Authors:  G Carrafiello; F Fontana; E Cotta; M Petullà; L Brunese; M Mangini; C Fugazzola
Journal:  Radiol Med       Date:  2011-06-04       Impact factor: 3.469

5.  Effect of dipyridamole on fluorodeoxyuridine cytotoxicity in vitro and in cancer patients.

Authors:  A C Buzaid; D S Alberts; J Einspahr; K Mosley; Y M Peng; K Tutsch; C P Spears; H S Garewal
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

6.  A 10-year survivor with unresectable hepatic metastases from sigmoid colon carcinoma treated with regional chemotherapy.

Authors:  S Takeda; K Hisatomi; S Nakano; K Okamoto; Y Nagafuchi; H Itoh; K Ohsato
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

7.  Effect on liver tumor growth in rats of allopurinol and 5-fluorouracil in combination with hepatic artery ligation.

Authors:  G Carlsson; B Gustavsson; L Hafström
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

Review 8.  Clinical pharmacokinetic advantages of new drug delivery methods for the treatment of liver tumours.

Authors:  J H Anderson; H W Warren; C S McArdle
Journal:  Clin Pharmacokinet       Date:  1994-09       Impact factor: 6.447

9.  Treatment of cancer of the liver. Twenty years' experience with infusion and resection in 414 patients.

Authors:  J S Stehlin; P D de Ipolyi; P J Greeff; C J McGaff; B R Davis; L McNary
Journal:  Ann Surg       Date:  1988-07       Impact factor: 12.969

Review 10.  Colorectal liver metastases.

Authors:  D Burke; T G Allen-Mersh
Journal:  Postgrad Med J       Date:  1996-08       Impact factor: 2.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.